Pulmonaryhypertensionnews.com5h
Weight-based Uptravi dosing appropriate for PAH children: Study
A body weight-adjusted regimen of Uptravi dosing for children and adolescents with PAH was deemed appropriate, according to a ...
Pulmonaryhypertensionnews.com3d
Phase 2 trial of tiprelestat for PAH receives FDA advice
The U.S. FDA has provided advice for Tiakis Biotech's Phase 2 clinical trial of tiprelestat for pulmonary arterial ...
Pulmonaryhypertensionnews.com5d
Alivegen’s ALG-801 named FDA orphan drug for PAH
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ALG-801, Alivegen ’s experimental ...
Pulmonaryhypertensionnews.com5d
How I struggle to manage chronic pain during the holidays
Chronic pain can be particularly difficult to manage during the holidays, says columnist Jen Cueva, who shares how PH disrupted her plans.